All Dr Linjie Luo (Postdoctoral Fellow at The University of Texas MD Anderson Cancer Center) articles
-
NewsNew dual CDK approach tackles drug-resistant breast cancer
A new preclinical study suggests that combining next-generation CDK2 inhibitors with existing CDK4/6 therapies could overcome drug resistance in breast cancer, delivering durable tumour control across multiple subtypes.